ÂÜÀòÂÒÂ×

Simon Friedensohn began their work experience in 2014 as a Research Intern at Roche, where they focused on Genetics & Genomics. In 2015, they joined ETH Zürich as a PhD Student, conducting research on engineering antibodies. During this time, they worked under Professor Sai Reddy in the Laboratory of Systems and Synthetic Immunology. In 2019, Friedensohn became a Co-Founder of deepCDR Biologics, a role they held until April 2022. Currently, they serve as the Director of Machine Learning & Data Engineering at Alloy Therapeutics, Inc.

Simon Friedensohn completed their Bachelor of Science in Biotechnology at ETH Zürich in an unspecified year. Simon then pursued a Master of Science in Biotechnologie, Systems Biology at the same institution, completing it in 2015. Subsequently, they went on to earn a Doctor of Philosophy in Biotechnology from ETH Zürich, completing the program in 2020.